As the most popular auxiliary diagnostic approach, protein biomarkers (e.g., cancer antigen 125, carcinoembryonic antigen, prostate-specific antigen, and cancer antigen 19-9) are usually restricted to one or several cancer types and have poor specificity28–32. This evidence concerns the gene MUC16 and cancer.